525 related articles for article (PubMed ID: 15717299)
1. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Laws HJ; Calaminus G; Göbel U
Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
[No Abstract] [Full Text] [Related]
2. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Fioredda F; Giacchino M; Castagnola E
Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
[No Abstract] [Full Text] [Related]
3. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
4. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
5. The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps.
Dudgeon JA
Practitioner; 1975 Sep; 215(1287):299-309. PubMed ID: 1101251
[No Abstract] [Full Text] [Related]
6. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
[TBL] [Abstract][Full Text] [Related]
8. [Measles, mumps, rubella: important health risks].
Rev Infirm; 2000 Oct; (64):13-5. PubMed ID: 11288443
[No Abstract] [Full Text] [Related]
9. [Indications and implementation of preventive vaccination in the inland].
Ehrengut W; Friedland R
Internist (Berl); 1979 Jun; 20(6):273-82. PubMed ID: 378890
[No Abstract] [Full Text] [Related]
10. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.
Dehghani SM; Shakiba MA; Ziaeyan M; Imanieh MH; Haghighat M; Sedaghat M; Alborzi A; Malek-Hosseini SA
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():26-31. PubMed ID: 25910330
[TBL] [Abstract][Full Text] [Related]
12. Need for monitoring vaccinated populations for immunity levels.
Horstmann DM
Prog Med Virol; 1973; 16():215-40. PubMed ID: 4585486
[No Abstract] [Full Text] [Related]
13. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
14. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
15. Low immunity against vaccine preventable diseases in Turkish HIV cohort.
Candevir A; Kuşcu F; Yıldırım F; Kömür S; Şentürk GÇ; İnal AS; Eser F; Çetiner S; Kurtaran B; Taşova Y
Turk J Med Sci; 2021 Oct; 51(5):2311-2317. PubMed ID: 33984893
[TBL] [Abstract][Full Text] [Related]
16. [Use of combined vaccines in children].
Plebani A
Ann Ig; 2002; 14(4 Suppl 5):85-91. PubMed ID: 12389297
[No Abstract] [Full Text] [Related]
17. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026
[TBL] [Abstract][Full Text] [Related]
18. [Strategies of vaccination for adult population in Spain in the actuality].
de Miguel AG
An R Acad Nac Med (Madr); 2006; 123(1):175-94. PubMed ID: 17172219
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
Cassidy WM; Jones G; Williams K; Deforest A; Forghani B; Virella G; Venters C
J Adolesc Health; 2005 Mar; 36(3):187-92. PubMed ID: 15737773
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
